DAFTAR PUSTAKA
1. Prihartini J, Lesmana LA, Manan C, Gani RA. Detection of oesofageal varices in liver cirrhosis using noninvasive parameters. Acta Med Indones-indones J Intern Med 2005;37:126-131.
2. Gupta TK, Chen L, Groszmann RJ. Pathophysiology of portal hypertension. Clin Liver Dis. 1997;1: 1-12.
3. Eyal A MD , Kovalev Y MD and Zuckerman E MD. Evaluation and Treatment of Esophageal Varices in the Cirrhotic Patient IMAJ 2013; 15 : 109-115.
4. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002; 122:1620-1630
5. D’Amico G, Criscuoli V, Fili D, Mocciaro F, Pagliaro L. Metaanalysis of trials for variceal bleeding. Hepatology 2002; 36:1023-1024
6. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652–659
7. Chalasani, N., C. Kahi. Improved patient survival after acute variceal bleeding : a multicenter, cohort study. Am J Gastroenterol 2003; 98(3):653–659
8. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002. Hepatology 2006; 43:500-505
9. Djojoningrat D. Hematemesis melena di bagian Ilmu penyakit dalam FK-UI/RSCM. Tesis Jakarta: Bagian Ilmu Penyakit Dalam FKUI, 1990
10.De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-176
11.Dite P et al. Esophageal varices. World Gastroenterology Organisation practice guideline: June 2008
12.De Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53:762-768
13.Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46:922-938.
15.D’Amico G, Pagliaro L, Bosch J. Treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
16.de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49:520-527
17.Castera L, Le Bail B, Roudot-Thoraval F, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50:59-68
18.Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum noninvasive markers: Results of a multicenter, large-scale study. J Hepatol 2010; 53:630-638
19.Hsieh Y.Y, Tung S.Y, Lee I.L, Lee K, Shen C.H, Wei K.L. Fibro Q: An Easy and Useful Noninvasive Test for Predicting Liver Fibrosis in Patients with Chronic Viral Hepatitis. Chang Gung Med J.2009; 32 (6):614-621
20.Cheney CP, Goldberg EM, Chopra S. Cirrhosis and portal hypertension : an overview. In : Friedman LS and Keeffe EB, eds.Handbook of Liver Disease. 2nd ed. China, Pa : Churchill Livingstone; 2012; 125-138
21.Wolf DC. Cirrhosis of the Liver. eMedicine Specialities. 29 Nov 2012.
22.World Health Organization. Hepatitis C - global prevalence (update). Weekly Epidemiological Record, 1999; 74:425-427
23.Suk TK. Revision and update on clinical practice guideline for liver cirrhosis. The Korean Journal of Hepatology 2012; 18:1-21
24.Bissell D, Maher JJ. Hepatic Fibrosis and Cirrhosis. In : Zakim D and Boyer TD, eds. Hepatolog. A Textbook of Liver Disease, vol 1, 3rd ed, Tokyo, 1996; 506
25.Hernomo K. Pengelolaan perdarahan masif varises esofagus pada sirosis hati. Thesis. Airlangga University Press, Surabaya. 1983
26.Benvegnu L, Gios M, Bocato S et.al. Natural history of compensated viral cirrhosis a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53:744-749
27.Garcia-Tsao D, Wongcharatrawee S. (VA Hepatitis C Resource Center Program). Treatment of patients with cirrhosis and portal hypertension literature review and summary of recommended interventions. Version 1 (October 2003)
29.Kuntz, Erwin., Kuntz, Han-Dieter. Hepatology : Textbook And Atlas. Germany : springer medizin verlag heilderberg. 2008
30.Erlingen S, Benhamou JP. Cirrhosis : clinical aspect. In : Oxford Textbook of Clinical Hepatology, Vol 1, 2nd ed.Hong Kong, Pa: Oxford Medical Publications; 1999;629-644
31.
Sharara AI, Rockey DC. Gastroesophageal Variceal Hemoorhage.N Engl
J Med 2001; 345:669-681
32. Sanyal A, Bosch J, Blei A, Arroyo V, Portal Hypertension and its complication. gastroenterology 2008;134:1715–1728.
33. R. de Franchis, “Stellate cells and the “reversible component” of portal hypertension,” Digestive and Liver Disease, 2000; vol. 32, no. 2, pp. 104–107
34.Y. Iwakiri and R. J. Groszmann, “Vascular endothelial dysfunction in cirrhosis,” Journal of Hepatology, 2007; vol. 46, no. 5, pp. 927–934.
35.D. C. Rockey, “Hepatic blood flow regulation by stellate cells in normal and injured liver,” Seminars in Liver Disease, 2001; vol. 21, no. 3, pp. 337–349 36.Wheatley AM , Zhang X - Y. Intrahepatic modulation of portal pressure and its
role in portal hypertension . Digestion 1998 ; 59 : 424 – 428 .
37.M. Fernandez, M. Mejias, E. Garcia-Pras, R. Mendez, J. C. Garcia-Pagan, and J. Bosch, “Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats,” Hepatology,2007; vol. 46, no. 4, pp. 1208–1217
38.Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing Portal Hypertension in liver diseases. Expert Rev. Gastroenterol. Hepatol.2003;7(2), 141–155 39.Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R,
Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R. B-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 2254-2261
40.Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488
41.D’Amico G, Garcia-Pagan JC, Luca A, Bosch J. HVPG reduction and prevention of variceal bleeding in cirrhosis. A systematic review. Gastroenterology 2006;131:1624
43.Laleman W, Van Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver International : 2005; 25: 1079–1090.
44.Merkel C, Marin R, Angeli P, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004;127:476–484
45.Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266–272
46.Bosch J et al. Portal Hypertension and Gastrointestinal Bleeding .Seminars in liver disease/2008; volume 28, number 1
47.De Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J Hepatol 2003;38:361–363
48.D’Amico G, de Franchis R. Upper digestive bleeding in cirrhosis:
post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612 49.Matsuo M, Kanematsu M, Kim T, Hori M, Takamura M, Murakami T,Kondo
H, Moriyama N, Nakamura H, Hoshi H. Esophageal Varices:Diagnosis with Gadolinium-Enhanced MR Imaging of the Liver for Patients with Chronic Liver Damage.AJR. 2003; 180:461-466.
50.Ishiguro H, Saito S, Imazu H, Aihara H, Kato T, Tajiri H.Esophageal Capsule Endoscopy for Screening Esophageal Varices among Japanese Patients with Liver Cirrhosis.Hindawi Publishing Corporation Gastroenterology Research and Practice.2012; 2012:1-6.
51.Stefanescu H, M. Grigorescu, M. Lupsor, A. Maniu, A. Crisan, B. Procopet, D. Feier, R. Badea. A New and Simple Algorithm for the Noninvasive Assessment of Esophageal Varices in Cirrhotic Patients Using Serum Fibrosis Markers and Transient Elastography 20(1):57-64.
52.Hsieh Y.Y, Tung S.Y, Lee K, Wu C.S, Wei K.L. Routine Blood Test to Predict Liver Fibrosis in Chronic Hepatitis C. World Journal of Gastroenterology. 2012; (18):746-753.
53.Mallet V , Vernier VD, Roussins C et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Alimentary Pharmacology and Therapeutics.2009; 29 : 409 -15.
54.Poynard T, Mathurin P, Lai CL, et al. A Comparison of Fibrosis progression in Chronic Liver Disease. J Hepatol 2003;38:257-265.
56.Khuram, M., N.Y. Khan, M. Arif, M.M. Irshad, K. Hammatul Bushra, Z. Hassan. Association of platelet count to splenic index ratio with presence of esophageal varices in patients with hepatitis C virus related compensated cirrhosis.Pak J Gastrenterol 2006; 20:37–42
57.Schepis, F., C. Camma, D. Niceforo. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?Hepatology. 2001; 33:333–8
58.Sarwar, S., A.A. Khan, A.K. Butt, F. Shafqat, K. Malik, I. Ahmad. Non-endoscopic prediction of esophageal varices in cirrhosis.J Coll Physicians Surg Pak 2005; 15:528–31.
59.Kujovich, J.L. 2005. Hemostatic defects in end stage liver disease. Crit Care Clin 2005; 21:563-587
60.Caldwell, S.H., M. Hoffman, T. Lisman, B.G. Macik. Coagulation disorders and hemostasis in liver disease : Pathophysiology and critical assessment of current management. Hepatology 2006; 44(4):1039-46
61.Tafarel,J.R., Tolentino, L.H., Correa, L.M., Bonilha, D.R., et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. European journalof gastroenterology & hepatology. 2011;23:754-758.
62.Okuda, M., K. Li, M.R. Beard. Mitochondrial injury, oxidative stress, and antioxidant are induced by hepatitis C virus core protein. Gastroenterology.2002; 122 : 366-75.
63.Fouad SA, Esmat S, et al. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. Word J of Gastroenterology. 2012 ; 2988-2992.
64.Hyder MA, Hasan M, Mohieldein AH. Comparative levels of ALT,AST, ALP and GGT in liver associated diseases. Euro.J.Exp.Bio. 2013;3(2):280-284. 65.Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis.
Gut 2006:Vi1-Vi12
